Therefore, promoting B10 cells in auto-immune diseases and inhibiting B cell IL-10 production in CLL are promising therapeutic tools, requiring a better comprehension of B cell IL-10 production regulation. The gene discussed is IL10; the disease is B-cell chronic lymphocytic leukemia.